
11 Sep 2023
Artificial intelligence in UK biopharma and healthcare 11/09/2023
Physiomics Plc (PYC:LON), 0.5 | EMV Capital PLC (EMVC:LON), 46.0 | IXICO Plc (IXI:LON), 11.8 | hVIVO plc (HVO:LON), 10.4 | Allergy Therapeutics plc (AGY:LON), 7.0 | Cambridge Cognition Holdings Plc (COG:LON), 37.5 | Feedback plc (FDBK:LON), 14.8 | Feedback Technology Corp. (8091:ROCO), 0 | DXS International Plc (DXSP:PLU), 2.5
Artificial intelligence (AI) continues to accelerate at full speed, first by imitating the workings of a human brain and now it is drawing concepts of evolution, sometimes with synthetic data, artificially manufactured for training purposes or for privacy protection, and sometimes not even with human intervention. In this note, we examine how AI is being developed and applied by the NHS and UK mid/small cap companies for the benefit of human health and wellbeing.
AI in drug discovery and devel ....

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Artificial intelligence in UK biopharma and healthcare 11/09/2023
Physiomics Plc (PYC:LON), 0.5 | EMV Capital PLC (EMVC:LON), 46.0 | IXICO Plc (IXI:LON), 11.8 | hVIVO plc (HVO:LON), 10.4 | Allergy Therapeutics plc (AGY:LON), 7.0 | Cambridge Cognition Holdings Plc (COG:LON), 37.5 | Feedback plc (FDBK:LON), 14.8 | Feedback Technology Corp. (8091:ROCO), 0 | DXS International Plc (DXSP:PLU), 2.5
- Published:
11 Sep 2023 - Author:
-
Pages:
43 -
Artificial intelligence (AI) continues to accelerate at full speed, first by imitating the workings of a human brain and now it is drawing concepts of evolution, sometimes with synthetic data, artificially manufactured for training purposes or for privacy protection, and sometimes not even with human intervention. In this note, we examine how AI is being developed and applied by the NHS and UK mid/small cap companies for the benefit of human health and wellbeing.
AI in drug discovery and devel ....